Public Health
publicado em 04/02/2010 às 20h00:00
   Dê o seu voto:

Faced with international recommendations regarding the use of sibutramine, the CFF, warning that the use involves a careful analysis

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



Foto: Steve Niedorf Photography/National Geographic
Man eats burger
  « Previous
next »  
Man eats burger

Sibutramine, a drug most used by Brazilians to control appetite, can not be sold nor recommended by doctors in Europe. The substance was banned in January 2010 by the European Medicines Agency. In the United States, the FoodDrug Administration (FDA) asked the manufacturers of drugs containing sibutramine that add to the inserts of the same contraindications for use in patients with a history of cardiovascular disease,

Faced with international recommendations regarding the use of sibutramine, the Federal Council of Pharmacy (CFF), through the Brazilian Center for Drug Information (Cebrim), warning that the use of sibutramine involves a careful analysis of risks, since the reduction of Body mass promoted by the drug is modest on the dangers it presents.

According to the Technical Note, the international recommendations, are based on the results of a study called Scout (Sibutramine Cardiovascular Outcomes), which showed an increased risk of stroke and myocardial infarction in obese or overweight and high risk of cardiovascular diseases.

Completed in 2009, the study indicated that the risk of developing cardiovascular disease, myocardial infarction, stroke and heart failure, increased by 16% in patients who used the drug, compared to those treated with placebo.

The Technical Note, signed by the pharmacist Emilia Victoria da Silva, Rogério Hoefler and Carlos Cezar Flores Vidotti, also explained that in Brazil, the sale of sibutramine is regulated by Decree 344/1998, Anvisa (National Agency for Sanitary Vigilance) requiring prescription to be presented and retained in the pharmacy.

Cebrim

The Cebrim faces the difficult problems associated with use of drugs such as indication, dosage, compatibility, interactions, adverse reactions, stability, etc.., To encourage rational use of them. The Cebrim, unlike the libraries and documentation centers, does not provide documents or references, but solutions to specific problems about drugs or a medical condition of a patient

Germany

Source: Isaude.net
   Palavras-chave:   Sibutramine    Drug    Weight Loss    Appetite Control    FoodDrug    CFF   
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story:
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story:


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
Sibutramine    Drug    Weight Loss    Appetite Control    FoodDrug    CFF   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.